Articles tagged with Inflammation
A new study published in Cancer suggests that inflammation from ADT is linked to higher levels of fatigue in prostate cancer patients. The researchers found an increase in the inflammation marker IL-6 in this group, which may contribute to symptoms.
A case of COVID-19 is reported to cause severe ocular neuropathy and panuveitis, a rare inflammatory condition affecting the uvea and retina. The condition was diagnosed in a 55-year-old male patient, who experienced sudden vision loss and pain.
Researchers identified two inflammatory pathways involving complement and the inflammasome that promote abnormal blood vessel formation in wet AMD. Blocking these pathways, including essential proteins of the inflammasome, may lead to improved therapies for this common blinding disease.
A large US study confirmed many COVID-19 complications, with pneumonia, respiratory failure, and sepsis being the most common. The study found that approximately 27% of patients developed serious conditions, while relatively low risks were associated with stroke and certain cardiovascular conditions.
A team of RUDN University biologists created a hibiscus-based dietary supplement for rainbow trout, reducing their sensitivity to ammonia pollution and improving stress resistance. The study found that the fish that received the supplement grew faster, had healthier livers, and stronger immune systems.
Researchers from RUDN University have developed a new method to analyze cytokines in nasal swabs to predict disease flow and prevent complications in asthma patients with accompanying diseases. The study found that monitoring specific cytokine profiles can help identify dangerous tendencies and allow for timely intervention.
Several patients using germicidal lamps developed painful inflammation of the cornea after exposure, prompting warnings from ophthalmologists. Manufacturer recommendations must be closely followed to prevent injury.
Scientists at Sanford Burnham Prebys Medical Discovery Institute have created a drug that can lure stem cells to damaged tissue, improving treatment efficacy for neurological disorders. The discovery could expand the use of stem cell therapies to new conditions such as heart disease or arthritis.
Researchers have found that excessive calcium triggers inflammation in ischemic strokes, leading to worse outcomes. Targeting this calcium overload may offer a new way to control inflammation and improve patient recovery.
A recent study has discovered a link between intestinal flora and inflammation in the central nervous system of patients with multiple sclerosis. IgA B cells play a key role in this process, accumulating in the cerebrospinal fluid and brain tissue during acute flares of the illness.
A team of researchers has discovered a drug-like compound that blocks the CD14 inflammatory protein, reducing inflammation and preventing cytokine storms in laboratory tests. The compound's potential as a new treatment for inflammatory diseases, including COVID-19, is being explored in pre-clinical trials.
Researchers found that mid-range levels of an immune marker at birth are associated with the lowest risk for autism spectrum disorder. Babies born with high levels of inflammation had a higher risk of developing ASD.
A new study shows that methotrexate significantly improves physical function and reduces inflammation in adults with primary knee osteoarthritis. Patients who received methotrexate treatment had improvements in WOMAC scores and reduced inflammatory markers, while those taking glucosamine showed no significant benefits.
A new study from Cedars-Sinai found that the ACE2 enzyme, which helps coronavirus infect cells, also plays a role in gut inflammation and patient outcomes in inflammatory bowel disease. Treatment with anti-inflammatory drugs for IBD may aid recovery from COVID-19.
A new study identifies an autoimmune antibody as a cause of COVID-19 blood clots in up to half of patients. Researchers found that blocking or removing these antibodies may improve outcomes for severely ill patients.
A new clinical study demonstrates that a non-living strain of Prevotella histicola can treat systemic inflammation in mild to moderate psoriasis through oral delivery. The treatment showed significant reductions in Psoriasis Area Severity Index (PASI) and Lesion Severity Scores (LSS), with minimal side effects.
Researchers have found a significant decline in average body temperature among healthy adults worldwide, with a drop of 0.09°F per year over the past two decades. The study, conducted in Bolivia and the US, suggests that improved hygiene, clean water, vaccinations, and medical treatment may be contributing factors.
A study published in Science Translational Medicine found that tryptophan, an amino acid present in turkey, combined with certain probiotics, can help individuals with celiac disease heal and manage symptoms. The research suggests targeting tryptophan metabolism in the gut may offer a potential therapy for better symptom control.
Research shows that childhood maltreatment affects girls more than boys, leading to higher levels of low-grade inflammation. Girls who experienced abuse at a young age are at risk for significant health problems later in life.
Researchers discovered that MG53 blocks inflammation and protects lungs from flu-induced death in mouse studies, offering a potential new therapy for the top-10 cause of global deaths. The treatment prevents excessive inflammation without affecting the virus itself.
A high-fibre diet has been found to offset chronic gastrointestinal damage caused by radiotherapy, reducing radiation-induced inflammation in the digestive system. This contradicts long-held clinical recommendations that advise a restricted fibre diet for cancer patients undergoing radiotherapy treatment.
A study from the University of Queensland found that a gene controlling inflammation increases the risk of obesity. Researchers discovered that variations in this gene lead to excessive inflammation in fat tissue, contributing to weight gain. By turning off the gene in mice, they were able to prevent weight gain and reduce diabetes risk
Researchers developed an optoelectronic implant that stimulates sensory neurons with light, inducing mild inflammation in animals. This study shows a neuroimmune interaction between pain and inflammation, offering new insights into future treatments.
A recent study published in iScience found that Δ9-tetrahydrocannabinol (THC) suppressed inflammation in the colon, preventing the onset of cancers caused by a carcinogen. THC treatment also prevented the development of colon cancers in mice.
A new study found that depression is associated with increased inflammation and metabolic changes, but not anxiety. The research used blood samples from over 300 people with depression and anxiety to identify biochemical markers, revealing distinct patterns of lipid metabolism and immune system involvement.
A RUDN geneticist discovered that a bifidobacterial surface protein can stop excessive inflammation in COVID-19 patients. The protein's fragment has shown effective binding to TNF-α, a key factor of inflammation, opening a prospect for developing new anti-inflammatory drugs.
A new study from Northwestern University finds that COVID-19 patients on ventilators are at risk of permanent nerve damage due to prone positioning. The study reveals that 12% to 15% of the most severely ill patients have experienced such injuries.
Researchers at Rutgers University are exploring the link between uncontrolled inflammation and microglial cells in the brain, aiming to develop new therapies for neurodegenerative diseases. The team is designing nanomedicines that can target microglia to tamp down inflammation and protect neurons.
A recent study has found a significant link between thyroid inflammation and anxiety disorders. Patients with anxiety were found to have thyroid gland inflammation that could be reduced by taking ibuprofen, suggesting that thyroid function may play an important role in the development of anxiety.
Researchers at Texas A\(M University have created a therapeutic derived from turmeric that reduces ocular inflammation in dogs with uveitis. The treatment bypasses intestinal and ocular barriers for improved absorption, offering a safer alternative to current medications.
Researchers at UIC have discovered that blood vessel cells play a crucial role in programming macrophages to reduce inflammation and promote tissue repair. The study found that Rspondin3, a protein released by blood vessels, helps guide the programming of macrophages.
Researchers discovered a type of long-lived immune cell that can provoke chronic inflammation in IBD patients, leading to abdominal pain and damage. The inflammatory T RM cell subtype may also escape into the bloodstream, affecting other parts of the body.
A Rutgers-Newark study discovered that lysozyme in the gut stimulates inflammation in some people with ulcerative colitis, leading to ulcers and sores in the large intestine. The study may help develop future treatments for inflammatory bowel disease by gaining insights into immune balance.
The study found that macrophages play a critical role in muscle inflammation, fibrosis, and regeneration. Researchers believe that therapeutic manipulations of these cells hold promise for promoting muscle injury repair and improving outcomes for individuals with muscular dystrophy.
Researchers create device to grow highly oxygen-intolerant bacteria in lab studies, revealing protective effects on human colon. They found that Faecalibacterium prausnitzii produces butyrate, which reduces inflammation and calms immune response.
Researchers used 3D brain organoids to model inflammation's effect on the blood-brain barrier, finding significant changes that contribute to its dysfunction. The study suggests these organoids can help understand disease mechanisms and optimize treatment strategies.
Researchers have found genes related to inflammation and stress that may help tailor treatments for depression. These findings support the idea that patients with treatment-resistant depression have heightened inflammation compared to those who respond to medication.
A new study from La Jolla Institute for Immunology reveals that a metabolic enzyme called ADA2 inhibits inflammation in blood vessels and restrains the immune system. The researchers found that ADA2's loss stimulates a robust innate immune response, which can lead to harmful inflammation.
Researchers found that CBD can help reduce cytokine storm and excessive lung inflammation caused by COVID-19. The study suggests that CBD may enable lungs to recover from damage, potentially reducing the need for mechanical ventilation.
Inflammageing, an age-associated phenomenon of increased general inflammation, may inhibit overall immunity and reduce vaccination efficacy in older people. Strategies to mitigate related effects include senolytic drugs or anti-inflammatory therapies.
Researchers have developed a technology to obtain microvesicles from human stem cells, showing significant biological activity and therapeutic potential. The induced microvesicles can reduce the intensity of immune response and may be used to treat inflammations and autoimmune syndromes.
A high-fat diet combined with antibiotic use significantly increases the risk of developing pre-IBD. The study suggests that this combination disrupts mitochondria in cells of the large intestinal lining, leading to gut inflammation and a vicious cycle of replacing good bacteria with harmful microbes.
A Basel study found that COVID-19 patients' lungs have insufficient levels of lopinavir and hydroxychloroquine to fight the virus. The drugs, previously thought to be potential treatments, were shown to be ineffective due to inflammation blocking their absorption.
A comprehensive review of COVID-19's non-respiratory effects reveals high rates of blood clots, kidney failure, and neurological symptoms. The review highlights the need for clinicians to consider COVID-19 as a multisystem disease requiring treatment beyond respiratory support.
The study found that oat and rye bran fibres support beneficial gut microbiota growth, improving cholesterol metabolism, gut barrier function, and reducing liver inflammation. Diets enriched with either bran type attenuated weight gain associated with a high-fat diet.
Walter and Eliza Hall Institute researchers used advanced imaging to visualize MLKL's role in necroptosis, a form of cell death triggered by inflammation. They found that inherited variants of MLKL are connected to human inflammatory diseases and have been subject to evolutionary pressures.
Administering the MMR (measles, mumps, rubella) vaccine could serve as a preventive measure to dampen septic inflammation associated with COVID-19 infection. Vaccination has no contraindications and may be especially effective for healthcare workers who can easily be exposed to COVID-19.
A study led by University College London found that elite athletes who adopted simple oral health measures reported reduced negative effects on performance related to poor oral health. The behaviour change programme improved oral health behaviours and reduced symptoms of gum inflammation, leading to improved sporting performance.
A new study reveals that poor oral health can exacerbate gut inflammation in IBD patients, potentially leading to reduced quality of life and surgery. The research suggests that promoting oral health could improve clinical outcomes in IBD, making it a crucial aspect of total body health.
Research from Kumamoto University reveals HTLV-1's mechanism of causing inflammation and cancer through viral gene HBZ's impact on immune cell reactivity to cytokines. The study found that IL-6 has suppressive effects on HBZ-induced pathogenicity, while its deficiency further promotes Treg differentiation.
A study reveals that fat cells' immune response amplifies inflammation, driving obesity-related disease. Type I Interferons produced by fat cells trigger a vicious cycle of inflammation, which can worsen metabolic issues and increase the risk of diseases like type 2 diabetes and COVID-19.
Researchers have discovered a novel drug that selectively controls excessive inflammation, a key driver of conditions like osteoarthritis and COVID-19. APPA demonstrates anti-inflammatory potential without compromising the body's ability to fight off infections.
A transgenic mouse model of HLH has been found to be effective in treating severe COVID-19 patients by calming the 'cytokine storm', a common feature of children battling secondary HLH. Ruxolitinib showed promising results, with 90% of patients showing CT scan improvement within 14 days.
Researchers identified a novel strategy to address underlying causes of LAD1 patients' symptoms by mimicking the efferocytosis process, which was absent in these individuals. The study found that small-molecule compounds that stimulate this process alleviated signs of inflammation and promoted bone regeneration in animal models.
Four critically ill COVID-19 patients improved significantly after receiving the experimental therapeutic CAP-1002, which contains cardiosphere-derived cells. The treatment helped reduce inflammation and showed no adverse effects, with all patients discharged from the hospital.
Researchers at Salk Institute discover two genes that regulate levels of healthy fats called FAHFAs, which decrease inflammation and increase insulin sensitivity. An experimental drug successfully increases FAHFA levels by blocking the activity of these genes, offering new insights into therapies for metabolic and inflammatory diseases.
Researchers aim to identify the mechanism of whole strawberry's anti-inflammatory effects on gut health. The study will test hypotheses that whole strawberry inhibits colon inflammation by restoring gut microflora balance.
A study published in eLife found that rapamycin, an immune-suppressing drug, reduces bone loss, inflammation, and changes to oral bacteria in older mice with gum disease. The treatment also reversed clinical features of periodontal disease, suggesting a potential approach for age-related dental problems.
A study by Charité - Universitätsmedizin Berlin reveals that the amoeba Entamoeba gingivalis plays a key role in periodontitis, causing inflammation and tissue destruction. The parasite's elimination may improve treatment outcomes for patients with gum disease.
Researchers propose a new therapeutic modality for sepsis by targeting cell-free chromatin in healthy cells. The study found that three cfCh-inactivating agents improved parameters related to sepsis, including increased survival rates in mice.